Colgate-Palmolive (CL) Competitors

Colgate-Palmolive (NYSE:CL) and Interparfums (NASDAQ:IPAR) are related companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

Is CL or IPAR more profitable?

Colgate-Palmolive has a net margin of 14.55% compared to Interparfums' net margin of 11.03%. Colgate-Palmolive's return on equity of 377.63% beat Interparfums' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Colgate-Palmolive	14.55%	377.63%	17.86%
Interparfums	11.03%	16.45%	11.14%

Does the media refer more to CL or IPAR?

In the previous week, Colgate-Palmolive had 12 more articles in the media than Interparfums. MarketBeat recorded 24 mentions for Colgate-Palmolive and 12 mentions for Interparfums. Colgate-Palmolive's average media sentiment score of 1.59 beat Interparfums' score of 1.27 indicating that Colgate-Palmolive is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Colgate-Palmolive	23 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Interparfums	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend CL or IPAR?

Colgate-Palmolive presently has a consensus price target of $98.92, suggesting a potential upside of 17.71%. Interparfums has a consensus price target of $162.00, suggesting a potential upside of 40.94%. Given Interparfums' stronger consensus rating and higher possible upside, analysts plainly believe Interparfums is more favorable than Colgate-Palmolive.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Colgate-Palmolive	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
Interparfums	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger valuation and earnings, CL or IPAR?

Colgate-Palmolive has higher revenue and earnings than Interparfums. Interparfums is trading at a lower price-to-earnings ratio than Colgate-Palmolive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Colgate-Palmolive	$20.10B	3.38	$2.89B	$3.56	23.61
Interparfums	$1.45B	2.54	$164.36M	$4.99	23.03

Is CL or IPAR a better dividend stock?

Colgate-Palmolive pays an annual dividend of $2.08 per share and has a dividend yield of 2.5%. Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.8%. Colgate-Palmolive pays out 58.4% of its earnings in the form of a dividend. Interparfums pays out 64.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Colgate-Palmolive has increased its dividend for 63 consecutive years and Interparfums has increased its dividend for 4 consecutive years.

Do insiders and institutionals have more ownership in CL or IPAR?

80.4% of Colgate-Palmolive shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 0.4% of Colgate-Palmolive shares are held by company insiders. Comparatively, 43.7% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has more risk & volatility, CL or IPAR?

Colgate-Palmolive has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.

Summary

Colgate-Palmolive beats Interparfums on 13 of the 19 factors compared between the two stocks.